Which pharmacologic class do corticosteroids belong to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pharmacologic Classification of Corticosteroids

Corticosteroids belong to the pharmacologic class of synthetic glucocorticoids (also called adrenal cortex hormones), which are anti-inflammatory and immunosuppressive agents that mimic naturally occurring hormones produced by the adrenal cortex. 1, 2, 3

Primary Pharmacologic Properties

Corticosteroids function through multiple mechanisms that define their therapeutic class:

  • Anti-inflammatory action: They reduce airway hyperresponsiveness, inhibit inflammatory cell migration and activation, and block late-phase allergic reactions by suppressing proinflammatory gene transcription and increasing anti-inflammatory mediators. 1

  • Immunosuppressive effects: They decrease leukocyte migration to inflammatory sites, reduce neutrophil-mediated tissue injury, and alter immune cell function through effects on cytokine production. 1, 4

  • Glucocorticoid activity: They influence carbohydrate and protein metabolism, stimulate gluconeogenesis, facilitate amino acid mobilization from muscle, and play a central role in the body's stress response. 5, 4

  • Mineralocorticoid activity (variable): Some corticosteroids possess mineralocorticoid properties affecting salt and water balance, though this varies by specific agent—hydrocortisone has mineralocorticoid activity while dexamethasone does not. 1, 5

Subclassification by Route of Administration

The corticosteroid class is further divided based on delivery method:

  • Systemic corticosteroids include oral agents (prednisone, prednisolone, methylprednisolone) and intravenous formulations (methylprednisolone, hydrocortisone, dexamethasone) that produce whole-body effects. 1, 2

  • Topical corticosteroids are classified into 7 potency classes (Class 1 ultra-high to Classes 6-7 low potency) based on cutaneous vasoconstriction assays, including agents like clobetasol propionate, betamethasone, and hydrocortisone. 2, 6

  • Inhaled corticosteroids (budesonide, fluticasone, mometasone) deliver localized airway effects with reduced systemic absorption compared to oral formulations. 1

  • Intranasal corticosteroids (fluticasone propionate, mometasone furoate, budesonide) provide topical anti-inflammatory effects in the nasal passages and sinuses. 1

  • Intratympanic corticosteroids (dexamethasone) allow direct delivery to the inner ear for conditions like sudden sensorineural hearing loss. 1

Molecular Classification

At the molecular level, corticosteroids are classified as:

  • Steroid hormone receptor agonists that bind to intracellular glucocorticoid receptors (GR) and mineralocorticoid receptors (MR), both members of the nuclear receptor transcription factor superfamily. 7, 8

  • These receptors initiate gene transcription for proteins mediating therapeutic effects, as well as rapid non-genomic effects through classical cell signaling pathways. 8

Common Pitfalls in Classification

  • Do not confuse corticosteroids with anabolic steroids—they are entirely different drug classes with opposite metabolic effects. 5

  • Recognize that "steroid" alone is ambiguous; the precise term is "corticosteroid" or "glucocorticoid" to distinguish from other steroid hormones (sex steroids, mineralocorticoids). 1

  • Understand that all corticosteroids have some degree of both glucocorticoid and mineralocorticoid activity, though the ratio varies dramatically—hydrocortisone has significant mineralocorticoid effects while dexamethasone has essentially none. 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evidence‑Based Recommendations for Corticosteroid Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Corticosteroid Classification and Usage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Steroids.

Current opinion in critical care, 2002

Research

Monitoring long-term oral corticosteroids.

BMJ open quality, 2017

Guideline

Topical Corticosteroid Potency Classification and Clinical Application

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

General overview of mineralocorticoid hormone action.

Pharmacology & therapeutics, 1999

Research

The multifaceted mineralocorticoid receptor.

Comprehensive Physiology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.